Information on medication adherence (using medication possession ratio) and total health care utilization/costs following enrollment were retrieved from the Medicare HMO database. Sixty-three older adults with psoriasis using topical corticosteroids therapy and enrolled in the Medicare HMO for a 2 year continuous period were included in the final sample. RESULTS: Nearly one-fifths of the patient population had depressive symptoms. Patients with psoriasis who had depressive symptoms at the time of enrollment were less likely to be adherent to topical corticosteroid medication (Spearman rho = -0.29, p < 0.01) and less likely to utilize health care resources as evidenced by lower health care costs (Spearman rho = -0.27, p < 0.05), after confounder adjustment. CONCLUSIONS: The prevalence of depressive symptoms in older adults with psoriasis is commonplace, with strong, yet unexplained correlations between presence of depressive symptoms and lower rates of medication and health care service use among these patients. Based on the various combinations of these 4 visual acuity groupings in the better-seeing (BSE) and worse-seeing eyes (WSE), subjects were classified into one of 10 subgroups. Multivariate linear regression determined if an association existed between various clinical variables and HRQoL. RESULTS: The mean age was 72 years; 63% were females. Mean scores were: VF-14, 66.1; TTO, 0.86; SRG, 0.89. Subjects with binocular visual dysfunction reported a lower HRQoL compared to those with monocular dysfunction (p < 0.001); mean differences in the TTO, SRG, and VF-14 were 0.19 (SE = 0.04), 0.14 (SE = 0.04), and 59.2 (SE = 3.9), respectively. Multivariate models demonstrated that only visual acuity subgrouping, a function of acuity in both the BSE and WSE, was associated with HRQoL score (overall eta 2 = 34.8%, p < 0.01, and partial eta 2 equal to 22% [TTO], 20% [SRG] and 60% ). Models including both BSE and WSE visual acuity explained an additional 10% in HRQoL variability compared to models with only BSE visual acuity. CONCLUSIONS: Subjects with binocular visual dysfunction reported a significantly lower HRQoL as compared to those with monocular dysfunction. These results suggest that binocular vision is a better predictor of HRQoL in AMD than only visual acuity in the BSE. The lack of specific ICD-9 codes and under selfreporting and diagnosis of ChHD suggests a need for a selfassessment survey to identify ChHD. This pilot study was conducted to validate a newly designed self-assessment questionnaire and the Skindex-29 QoL instrument for use by ChHD patients. METHODS: A clinical questionnaire, consisting of 16 questions, was developed to identify patients with ChHD and to assess its severity, through patient self-administration. Sensitivity, specificity, and receiver operating characteristic (ROC) curve were used to evaluate how closely the ChHD diagnosis based on self-assessment concurred with physician's diagnoses. Also, Skindex-29, a QoL instrument with 29 questions not previously validated in a ChHD population, was evaluated for internal consistency and construct validity for ChHD patients in this study. Forty-patients (ChHD n = 20; other skin disorders n = 20), with a mean age of 46.6 ± 14.8 years and 30% males, were randomly selected from a dermatology clinic in Louisville, Kentucky for this pilot study. RESULTS: The performance of the clinical questionnaire matched the physicians' diagnosis in identifying ChHD with a sensitivity of 85%, a specificity of 95%, and an area under the ROC curve of 0.83. The internal consistency of the Skindex-29 was higher than that reported previously in a general dermatology population, with a Cronbach alpha of 0.77 to 0.94 for
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